oral vs subq semaglutide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Peptidyl and Non-Peptidyl Oral Glucagon-Like

How Side Effects Compare Both semaglutide and tirzepatide share similar digestive side effects because they affect appetite and digestion in related ways

Antioxidant activity with increased endogenous levels of vitamin C, E, and A following dietary supplementation with a combination of glutathione and resveratrol precursors

The initial users include drugmaker Amgen Inc., vaccine maker Moderna Inc

Source: DailyMed (Mounjaro), DailyMed (Ozempic) Drug interactions of Mounjaro and Ozempic The most common interactions with Mounjaro and Ozempic happen with drugs that also lower blood sugar, like insulin and some oral diabetes medications